SE7704359L - PROCEDURE FOR ENRICHMENT OF A PLACENTAS-SPECIFIC GLYCOPROTEIN - Google Patents

PROCEDURE FOR ENRICHMENT OF A PLACENTAS-SPECIFIC GLYCOPROTEIN

Info

Publication number
SE7704359L
SE7704359L SE7704359A SE7704359A SE7704359L SE 7704359 L SE7704359 L SE 7704359L SE 7704359 A SE7704359 A SE 7704359A SE 7704359 A SE7704359 A SE 7704359A SE 7704359 L SE7704359 L SE 7704359L
Authority
SE
Sweden
Prior art keywords
placentas
enrichment
procedure
support
specific glycoprotein
Prior art date
Application number
SE7704359A
Other languages
Unknown language ( )
Swedish (sv)
Inventor
H Bohn
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of SE7704359L publication Critical patent/SE7704359L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors

Abstract

In order to concentrate the placenta-specific protein PP5, a PP5-containing protein solution is brought into contact, at a pH of between 4 and 9, with an antibody against PP5 which is bound to an insoluble support. The support with the PP5 bound to it is separated off from the liquid phase. In order to release the PP5, this support is treated with an aqueous medium of a pH of from 2 to 4, or with a solution of a substance which dissociates protein bonds at a pH of from 4 to 9. The PP5 which is obtained can be used in a diagnostic agent for detecting PP5 and antibodies directed against PP5.
SE7704359A 1976-04-17 1977-04-15 PROCEDURE FOR ENRICHMENT OF A PLACENTAS-SPECIFIC GLYCOPROTEIN SE7704359L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2616984A DE2616984C3 (en) 1976-04-17 1976-04-17 Method for the isolation and purification of a placenta-specific glycoprotein

Publications (1)

Publication Number Publication Date
SE7704359L true SE7704359L (en) 1977-10-18

Family

ID=5975638

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7704359A SE7704359L (en) 1976-04-17 1977-04-15 PROCEDURE FOR ENRICHMENT OF A PLACENTAS-SPECIFIC GLYCOPROTEIN

Country Status (20)

Country Link
JP (1) JPS52154509A (en)
AT (1) AT362057B (en)
AU (1) AU517434B2 (en)
BE (1) BE853711A (en)
CA (1) CA1101847A (en)
CH (2) CH630643A5 (en)
DE (1) DE2616984C3 (en)
DK (1) DK168577A (en)
ES (2) ES457714A1 (en)
FI (1) FI60875C (en)
FR (1) FR2348222A1 (en)
GB (1) GB1555197A (en)
IE (1) IE44824B1 (en)
IL (1) IL51883A (en)
IT (1) IT1075832B (en)
LU (1) LU77143A1 (en)
NL (1) NL7703963A (en)
NO (1) NO146747C (en)
NZ (1) NZ183878A (en)
SE (1) SE7704359L (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2640387C3 (en) * 1976-09-08 1981-01-22 Behringwerke Ag, 3550 Marburg Tissue-specific protein and method for its production
DE2720704C2 (en) * 1977-05-07 1986-09-25 Behringwerke Ag, 3550 Marburg New glycoprotein, process for its production and its uses
DE2745680A1 (en) * 1977-10-11 1979-04-12 Behringwerke Ag CONTRACEPTIVE MEANS
EP0029893B1 (en) * 1979-11-02 1987-05-20 Karl Prof. Dr. Theurer Process for concentration of tumor-inhibiting substances
DE3013724A1 (en) 1980-04-10 1981-10-15 Behringwerke Ag, 3550 Marburg NEW PROTEIN PP (DOWN ARROW) 9 (DOWN ARROW), METHOD FOR ITS ENRICHMENT AND PRODUCTION AND ITS USE
DE3334405A1 (en) * 1983-09-23 1985-04-04 Behringwerke Ag, 3550 Marburg MEMBRANE ASSOCIATED PROTEINS (MP (DOWN ARROW) 2 (DOWN ARROW)), METHOD FOR THEIR EXTRACTION AND USE
NZ212523A (en) * 1985-06-24 1989-01-06 Univ Massey Mobile phase for purification of proteins by high performance liquid chromatography
US20030220233A1 (en) 1994-01-24 2003-11-27 Neorx Corporation Radiolabeled annexins
US5968477A (en) 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator
CA2190727C (en) * 1994-05-19 2006-07-18 Sudhakar Kasina Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging
US6005083A (en) 1997-03-28 1999-12-21 Neorx Corporation Bridged aromatic substituted amine ligands with donor atoms

Also Published As

Publication number Publication date
AU517434B2 (en) 1981-07-30
CA1101847A (en) 1981-05-26
AT362057B (en) 1981-04-27
CH632091A5 (en) 1982-09-15
NL7703963A (en) 1977-10-19
FI771186A (en) 1977-10-18
FI60875B (en) 1981-12-31
CH630643A5 (en) 1982-06-30
JPS52154509A (en) 1977-12-22
IL51883A (en) 1980-02-29
IE44824L (en) 1977-10-17
NO771316L (en) 1977-10-18
NO146747C (en) 1982-12-01
IT1075832B (en) 1985-04-22
IL51883A0 (en) 1977-06-30
FI60875C (en) 1982-04-13
ES457714A1 (en) 1978-02-16
ES462699A1 (en) 1978-07-01
LU77143A1 (en) 1977-11-14
FR2348222A1 (en) 1977-11-10
FR2348222B1 (en) 1980-02-08
BE853711A (en) 1977-10-18
ATA266377A (en) 1980-09-15
NO146747B (en) 1982-08-23
NZ183878A (en) 1980-04-28
DE2616984B2 (en) 1981-01-29
AU2431977A (en) 1978-10-19
GB1555197A (en) 1979-11-07
DK168577A (en) 1977-10-18
IE44824B1 (en) 1982-04-07
DE2616984C3 (en) 1981-10-29
DE2616984A1 (en) 1977-10-20

Similar Documents

Publication Publication Date Title
LV10538A (en) Influence of immunologically binding agent on biological fluid and diagnostic agent
SE7613498L (en) PROCEDURE FOR CONNECTING BIOLOGICAL SUBSTANCES BY COVALENT BONDS
SE8102558L (en) IMMUNOLOGICAL DETERMINATION METHOD
SE7613487L (en) MAGNETIC GEL FOR IMMUNOENZYMATIC ANALYSIS
SE7704359L (en) PROCEDURE FOR ENRICHMENT OF A PLACENTAS-SPECIFIC GLYCOPROTEIN
SE7614183L (en) PROCEDURE AND DEVICE FOR PREGNANCY TESTS
ES511797A0 (en) "METHOD FOR TESTING ANTIGEN-ANTIBODY REACTIONS".
SE7903821L (en) KINETICAL SATURATION OF THE GLYCOSE CONCENTRATION IN BODY WELDING AND PREPARATION
KR850002385A (en) Method and reagent for measuring PIVKA-II
NO881904L (en) PROCEDURE FOR SELECTIVE IMMUNOLOGICAL DETERMINATION OF INTACT PROCOLLAGEN PEPTID (TYPE III) AND PROCOLLAGEN (TYPE III) IN BODY LIQUID, AND AGENT FOR ITS IMPLEMENTATION.
KR900004935A (en) Lipoprotein I (OMPI), Pseudomonas aeruginosa
SE7606082L (en) PROCEDURE FOR DETECTION OF ANTIBODIES IN BODY SWEATSHIPS USING KENDA ANTIGENS OR FOR DETERMINING ANTIGENES USING KENDA ANTIBODIES FROM BODYWATCHES
DE3688072T2 (en) IMMUNITY TEST PROCEDURE AND SET.
GB1151608A (en) A Method for Determining Vitamin B12
DK432485D0 (en) METHOD FOR CONCENTRATING AND DETECTING BIOMOLECULES AND CELLS AND DEVICE FOR USE THEREOF
ATE124706T1 (en) METHOD FOR ISOLATION OF BASAL MEMBRANE PROTEINS FROM HUMAN AND ANIMAL TISSUES.
AXELSEN et al. 22. Reversed Rocket Immunoelectrphoresis
ATE78342T1 (en) METHODS OF DETECTING PREGNANCY DISORDERS.
FR2385099A1 (en) Rapid determn. of antigens and antibodies - by marking with enzyme, complex formation on a support and acid elution
ATE14161T1 (en) METHODS FOR DETERMINING IMMUNE COMPLEXES.
ES446939A1 (en) Process for the enrichment of pregnancy specific -glycoprrotein
FI831095L (en) BESTAEMNINGSFOERFARANDE FOER ANTIGEN
SE7709421L (en) SYSTEM FOR SATURATION OF RADIO ACTIVITY IN LABELED BIOPOLYMERS
DE3781808T2 (en) DIAGNOSTIC TEST PROCEDURE FOR PIG DYSENTERIES.
ES2002578A6 (en) A process for the preparation of diagnostic reagents.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7704359-4